Regulations Across ASEAN
Regulatory news, updates, and insights for countries in the ASEAN region presented by the Carver Agents team
- Indexed episodes, last 90 days
- 10
- Latest publication
- Sep 7, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 6, 2026
Latest episodes
[ASEAN] Key Regulatory Insights on Health, Finance & Cross-Border Policies (opens the original)
Read excerpt
Covering FTA Negotiations, WHO South-East Asia, Emergency Use Authorization, Tuberculosis, Malaysia. Explore major regulatory updates including WHO South-East Asia’s health priorities, Malaysia’s new Cross-Border Insolvency Act, Emergency Use Authorization advances, and tuberculosis elimination efforts within ASEAN.
[ASEAN] Key Regulatory Updates on Deposit Insurance and Sanctions Compliance (opens the original)
Read excerpt
Covering OFAC, BPR, BPRS, BPR Citra Bersada Abadi, Bilateral Cooperation. Insights on OFAC sanctions enforcement, deposit insurance claims for BPR Citra Bersada Abadi and BPRS Hasanah Mandiri, and bilateral regulatory cooperation in ASEAN. Focus on compliance timelines and penalties in the banking sector.
[ASEAN] Key Regulatory Updates on Healthcare and Financial Liquidation (opens the original)
Read excerpt
Covering Syphilis, Pneumonia, Breast Cancer, Likuidasi, Bekasi. This episode covers critical regulatory developments in Syphilis, Pneumonia, Breast Cancer clinical guidelines, and financial liquidation processes involving Indonesian banks, including Bekasi-related activities.
[ASEAN] Regulatory Insights on MenQuadfi, Islamic Finance & Vaping Controls (opens the original)
Read excerpt
Covering MenQuadfi, Islamic Finance, Etomidate, Merger, Vaping. Explore key regulatory developments in ASEAN covering MenQuadfi vaccine expansion, Islamic Finance disclosure collaboration, enforcement on etomidate vaping, and a major merger involving Wilmar and ABF. Stay informed on evolving market and compliance landscapes.
[ASEAN] Key Regulatory Updates on Labuan FSA, OFAC, LIBA & Antitrust (opens the original)
Read excerpt
Covering OFAC, Labuan FSA, Generalised Myasthenia Gravis, LIBA, Antitrust. Insights on OFAC enforcement, Labuan FSA compliance actions, LIBA dialogue, and developments impacting Generalised Myasthenia Gravis and antitrust sectors across ASEAN markets.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.